Colgate-Palmolive (NYSE:CL) Shares Bought by NorthRock Partners LLC

NorthRock Partners LLC grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 105.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,409 shares of the company's stock after buying an additional 4,314 shares during the quarter. NorthRock Partners LLC's holdings in Colgate-Palmolive were worth $764,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Barclays PLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. Brookstone Capital Management lifted its stake in Colgate-Palmolive by 12.0% in the fourth quarter. Brookstone Capital Management now owns 19,455 shares of the company's stock worth $1,769,000 after acquiring an additional 2,089 shares during the last quarter. Sovereign Financial Group Inc. lifted its stake in Colgate-Palmolive by 3.6% in the fourth quarter. Sovereign Financial Group Inc. now owns 4,215 shares of the company's stock worth $383,000 after acquiring an additional 146 shares during the last quarter. SeaCrest Wealth Management LLC increased its holdings in Colgate-Palmolive by 2.1% in the fourth quarter. SeaCrest Wealth Management LLC now owns 7,415 shares of the company's stock valued at $674,000 after buying an additional 154 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC raised its stake in Colgate-Palmolive by 13.4% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 10,767 shares of the company's stock valued at $979,000 after buying an additional 1,272 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CL has been the topic of a number of recent analyst reports. Citigroup increased their price objective on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. Raymond James restated an "outperform" rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Barclays decreased their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of "Hold" and an average target price of $102.12.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded up $0.49 on Monday, reaching $91.72. 3,769,888 shares of the company were exchanged, compared to its average volume of 4,654,734. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The firm has a market cap of $74.33 billion, a price-to-earnings ratio of 26.06, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39. The company has a 50-day moving average of $91.65 and a 200-day moving average of $91.27.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same period in the prior year, the company posted $0.86 EPS. The business's revenue for the quarter was down 3.0% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were given a $0.52 dividend. The ex-dividend date of this dividend was Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.27%. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive announced that its board has approved a stock repurchase program on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.